{"title":"轻度认知障碍","authors":"M. Janelidze, N. Botchorishvili","doi":"10.5772/INTECHOPEN.75509","DOIUrl":null,"url":null,"abstract":"Mild cognitive impairment (MCI) refers to cognitive decline from a previous level of functioning, both subjectively and by objective evidence. MCI is an intermediate stage of cognitive impairment between the normal cognitive aging and dementia. The concept of mild cognitive impairment originally evolved with an intention to characterize the pre-dementia phase of cognitive impairment. MCI is a known risk factor for dementia. Patients with MCI may represent an optimal target population for pharmacological and non-pharmacological interventions. The following chapter provides an overview of the concept of mild cognitive impairment, epidemiological data, current diagnostic criteria, clinical approach and management of MCI.","PeriodicalId":437558,"journal":{"name":"Alzheimer's Disease - The 21st Century Challenge","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Mild Cognitive Impairment\",\"authors\":\"M. Janelidze, N. Botchorishvili\",\"doi\":\"10.5772/INTECHOPEN.75509\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Mild cognitive impairment (MCI) refers to cognitive decline from a previous level of functioning, both subjectively and by objective evidence. MCI is an intermediate stage of cognitive impairment between the normal cognitive aging and dementia. The concept of mild cognitive impairment originally evolved with an intention to characterize the pre-dementia phase of cognitive impairment. MCI is a known risk factor for dementia. Patients with MCI may represent an optimal target population for pharmacological and non-pharmacological interventions. The following chapter provides an overview of the concept of mild cognitive impairment, epidemiological data, current diagnostic criteria, clinical approach and management of MCI.\",\"PeriodicalId\":437558,\"journal\":{\"name\":\"Alzheimer's Disease - The 21st Century Challenge\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alzheimer's Disease - The 21st Century Challenge\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5772/INTECHOPEN.75509\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's Disease - The 21st Century Challenge","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/INTECHOPEN.75509","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Mild cognitive impairment (MCI) refers to cognitive decline from a previous level of functioning, both subjectively and by objective evidence. MCI is an intermediate stage of cognitive impairment between the normal cognitive aging and dementia. The concept of mild cognitive impairment originally evolved with an intention to characterize the pre-dementia phase of cognitive impairment. MCI is a known risk factor for dementia. Patients with MCI may represent an optimal target population for pharmacological and non-pharmacological interventions. The following chapter provides an overview of the concept of mild cognitive impairment, epidemiological data, current diagnostic criteria, clinical approach and management of MCI.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
